United States Vaccine Adjuvants Market 2025 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

The global vaccine adjuvants market size reached US$ 703.15 Million in 2024 from US$ 661.09 Million in 2023 and is expected to reach US$ 1,280.35 Million by 2033, growing at a CAGR of 6.9% during the forecast period 2025-2033.

Key Development:

United States: Recent Industry Developments

✅ In October 2025, the CDC's Advisory Committee on Immunization Practices initiated a multi-year review of the U.S. childhood vaccine schedule, focusing on the safety and effectiveness of vaccine ingredients, including aluminum-based adjuvants.

✅ In October 2025, Inimmune announced that its leadership team will present multiple sessions on next-generation adjuvants at the World Vaccine Congress in Amsterdam, showcasing advancements in adjuvant technologies.

✅ October 2025 - TransCode Therapeutics announced the acquisition of Polynoma, a privately-held biotechnology firm specializing in immuno-oncology. This strategic move aims to enhance TransCode's pipeline with Polynoma's Phase 3-ready melanoma vaccine, seviprotimut-L, which utilizes a novel adjuvant platform.

✅ In August 2025, Sanofi expanded its licensing agreement with Novavax to include broader rights for the use of Novavax's Matrix-M adjuvant in various vaccine candidates.

Japan: Recent Industry Developments

✅ In October 2025, Inimmune's participation in the World Vaccine Congress in Amsterdam highlighted Japan's collaborative efforts in advancing adjuvant research and development.

✅ In August 2025, the Coalition for Epidemic Preparedness Innovations (CEPI) launched a vaccine adjuvant library, allowing developers to request and test multiple adjuvant samples to optimize vaccine efficacy.

✅ In August 2025, Sumitomo Pharma introduced a novel TLR7 agonist adjuvant, aiming to enhance the immune response in vaccine formulations, particularly for infectious diseases.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/vaccine-adjuvants-market?sb

Vaccine adjuvants are compounds added to vaccines to boost and modulate the immune response against the target antigen. They enhance vaccine effectiveness, enable lower antigen doses, and help provide longer-lasting and broader immunity.

Key Players:

=> GSK, Dynavax Technologies, Novavax, SPI Pharma, Agenus Inc., CSL, InvivoGen, Brenntag Nicaragua, S.A., and OZ Biosciences, among others.

Growth Forecast Projected:

The Global Vaccine adjuvants Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2033. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Vaccine adjuvants Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=vaccine-adjuvants-market

Key Segments:

➥ By Product Type: Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants, Others
➥ By Route of Administration: Intramuscular, Oral, Intradermal, Subcutaneous, Intranasal
➥ By Application: Infectious Diseases, Cancer, Others
➥ By End User: Pharmaceutical & Biotech Companies, Research Institutes, Others

Regional Analysis for Vaccine adjuvants Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Vaccine adjuvants producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Vaccine adjuvants revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/vaccine-adjuvants-market?sb

FAQ

What is the current size of the Vaccine adjuvants Market?

A: In 2024, the Vaccine adjuvants Market was valued at US$ 703.15 Million, reflecting its strong industry presence.

Q2: How large is the Vaccine adjuvants Market expected to be by 2031?

A: By 2033, industry forecasts suggest the Vaccine adjuvants Market will grow to around US$ 1,280.35 Million, demonstrating significant expansion.

Q3: What is the growth rate of the Vaccine adjuvants Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 6.9% during the forecast period from 2025 to 2031.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.